| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344170A Methods for inactivating pathogens using broad-spectrum pulsed light |
| 04/10/2002 | CN1344165A Antiviral agent in form of nose drops |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants |
| 04/10/2002 | CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 04/10/2002 | CN1343788A Polypeptide-protein 9.57 containing DNA topoisomerase II characteristics and polynucleotide for coding it |
| 04/10/2002 | CN1343787A Polypeptide-protein 9.24 containing methionine aminopeptidase characteristics and polynucleotide for coding it |
| 04/10/2002 | CN1343786A Polypeptide-human aminopeptidase-B 54.34 and polynucleotide for coding it |
| 04/10/2002 | CN1343785A Polypeptide-human ATP-dependent RNA uncoiling enzyme 10.78 and polynucleotide for coding it |
| 04/10/2002 | CN1343784A Polypeptide-protein 9.02 containg beta-lactamase structure domain and polynucleotide for coding it |
| 04/10/2002 | CN1343783A Polypeptide-Ser/Thr/tyr specific protein kinase 69.52 and polynucleotide for coding it |
| 04/10/2002 | CN1343782A Polypeptide-superoxide dismutase 11.88 and polynucleotide for coding it |
| 04/10/2002 | CN1343781A Polypeptide-protein 9.57 containing NADH dehydrogenase structure domain and polynucleotide for coding it |
| 04/10/2002 | CN1343780A Polypeptide-protein 10.89 containing biopterin-dependent aromatic amino acid hydroxylase characteristics and polynucleotide for coding it |
| 04/10/2002 | CN1343779A Polypeptide-protein 12.21 containing peroxidase characteristics and polynucleoitde for coding it |
| 04/10/2002 | CN1343778A Polypeptide-nucleotide reductase 16.61 and polynucleotide for coding it |
| 04/10/2002 | CN1343776A Polypeptide-DNA polymerase 9.02 and polynucleotide for coding it |
| 04/10/2002 | CN1343725A Human angiogenin-like protein and coding sequence and application thereof |
| 04/10/2002 | CN1343724A GDNF mutant and its medical application |
| 04/10/2002 | CN1343723A Human tumor associated gene in 1-zone 3-band 3-subband of short arm of human chromosome No.17 and its coding protein |
| 04/10/2002 | CN1343689A Short-chain neurotoxin of sea serpent and gene for coding it |
| 04/10/2002 | CN1343688A Human NIP2 associated protein and coding sequence and application thereof |
| 04/10/2002 | CN1343685A Polypeptide-proliferating cell antigen P120-51.59 and polynucleotide for coding it |
| 04/10/2002 | CN1082373C Medicines and drinking products for prevention and treatment gastrointestinal diseases |
| 04/10/2002 | CN1082368C HCG liquid formulations |
| 04/09/2002 | US6369295 Uses of transgenic mouse containing a type X collagen mutant |
| 04/09/2002 | US6369252 Structured lipids |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369208 Influenza endonuclease apatamer that inhibits influenza endonuclease and is resistant to cleavage by said enzyme |
| 04/09/2002 | US6369205 Integrin-linked kinase and its uses |
| 04/09/2002 | US6369204 Receptor known to be expressed in large amounts on the surface of osteoclasts and associated with bone resorption; use treating osteoporosis and/or in the inhibition of tumor cell growth |
| 04/09/2002 | US6369203 Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 04/09/2002 | US6369201 For increasing muscle synthesis and treating disease in vertebrate subjects, for reducing myostatin activity |
| 04/09/2002 | US6369198 Signal transducer and activator of transcription (stat) proteins; |
| 04/09/2002 | US6369197 Potassium channel interactors and uses therefor |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369106 Treatment of ischemic brain injuries with brain targeted anti oxidant compounds |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369063 Selective factor Xa inhibitors |
| 04/09/2002 | US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy |
| 04/09/2002 | US6369034 For therapy of cancer, restenosis, and atherosclerosis |
| 04/09/2002 | US6369033 For therapy of multiple sclerosis |
| 04/09/2002 | US6369031 Administering to combination of human protein z and human protein z-dependent protease inhibitor (zpi) to inhibit factor xa formation |
| 04/09/2002 | US6369030 Inhibitors of histone acetyltransferases (HATs) and uses thereof |
| 04/09/2002 | US6369029 Method of stimulating osteogenesis using a c-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) |
| 04/09/2002 | US6369028 For combatting endoparasites |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368863 Reagents and methods for modulating gene expression through RNA mimicry |
| 04/09/2002 | US6368858 Modulation of multicellular aggregates by pressure from growth in a matrix |
| 04/09/2002 | US6368856 An antisense nucleotide; therapy for metabolic diseases, diabetes |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368845 Polypeptides having L-asparaginase activity |
| 04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
| 04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368822 Fibroblast growth factor 13 |
| 04/09/2002 | US6368812 Exposing transfected cells with dna or infected rna encoding a galanin receptor and a chemical that is a possible receptor activator; measure the receptor activity in the absence and presence of the chemical with the transfected cells |
| 04/09/2002 | US6368811 Syndecan interacting proteins and the use thereof |
| 04/09/2002 | US6368810 A monoclonal antibody; for diagnosis, prevention and therapy of inflammation and cancer |
| 04/09/2002 | US6368802 A method for synthesizing rna oligonucleotides by mixing a circular single stranded template, with a nucleotide sequence complementary to the target rna oligonucleotide, and mix with polymerase enzyme and primer to create rna oligonucleotides |
| 04/09/2002 | US6368796 Methods of detection and treatment of breast cancer |
| 04/09/2002 | US6368794 A cdna encoding a polypeptide: diagnosising and monitoring cellular proliferative diseases and cancers |
| 04/09/2002 | US6368790 cDNA encoding P2P proteins and use of P2P cDNA derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368788 Method of treating complications in immunodepressed states resulting from HIV infection |
| 04/09/2002 | US6368787 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 04/09/2002 | US6368785 Anti-coagulation of blood, plasma or synovial fluid products using iso-citrate |
| 04/09/2002 | US6368630 Modulated release from biocompatible polymers |
| 04/09/2002 | US6368605 Method for treating cancer with a neurotoxin to improve patient function |
| 04/09/2002 | US6368601 Isolated dna |
| 04/09/2002 | US6368598 Administering complex of polyamine carrier, drug and connector |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368596 Monoclonal antibody complex; anticancer agent |
| 04/09/2002 | US6368594 Pure polypeptide |
| 04/09/2002 | US6368593 Enhanced immunogenic cell populations prepared using H2 receptor antagonists |
| 04/09/2002 | US6368585 Opthalmic compositions and methods |
| 04/09/2002 | US6367479 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/09/2002 | CA2263800C A thrombin blood fraction for use in a medical procedure |
| 04/09/2002 | CA2249744C Oral peptide pharmaceutical products |
| 04/09/2002 | CA2233698C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/09/2002 | CA2141691C Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 04/09/2002 | CA2128407C Synthetic peptides for a rubella vaccine |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/09/2002 | CA2084790C Endonucleases |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/06/2002 | CA2358239A1 Novel siglec-like gene |
| 04/06/2002 | CA2358235A1 Novel siglec gene |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002027033A1 Antisense modulation of mekk4 expression |
| 04/04/2002 | WO2002027022A2 Methods for diagnosing and treating autosomal dominant optic atrophy |
| 04/04/2002 | WO2002027019A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/04/2002 | WO2002026999A2 Regulation of human adam-ts-like protein |